发明名称 LIVER SELECTIVE THERAPY
摘要 A method of pharmaceutical therapy comprising administering a pharmaceutical complementary medicine or herbal product orally at a dose sufficient to provide a clinically effective level in the portal vein and less than that required to provide a clinically effective blood level in the peripheral circulation to thereby provide a dose-delivery rate having a selective clinical effect in the liver.
申请公布号 CA2389616(A1) 申请公布日期 2001.05.10
申请号 CA20002389616 申请日期 2000.11.01
申请人 HOWARD J. SMITH ASSOCIATES PTY LTD. 发明人 SMITH, HOWARD J.
分类号 A61K9/16;A61K9/22;A61K31/138;A61K31/19;A61K31/22;A61K31/351;A61K31/366;A61K31/40;A61K31/56;A61K31/573;A61P1/16;A61P3/06;A61P9/12;A61P31/12;(IPC1-7):A61K31/13;A61K31/365;A61K31/57 主分类号 A61K9/16
代理机构 代理人
主权项
地址